New report on Renal Denervation Devices is a novel approach for the treatment of resistant hypertension. It is an invasive, endovascular catheter based procedure that involves the use of radiofrequency ablation. Several devices have been approved for this procedure. The incidence of hypertension has been increasing worldwide, despite the availability of effective anti-hypertensive medicines. Hypertension remains uncontrolled in the case of several patients for various reasons, including inadequate treatment. High prevalence of uncontrolled & treatment resistant hypertension, the short duration & permanent effect of renal denervation and the rapid development of RDN devices are factors that are driving the growth of the renal denervation devices market.

The renal denervation devices market has been segmented on the basis of technology, product and geography. On the basis of technology, the market is segmented into radiofrequency, ultrasound, micro-infusion and others.

The renal denervation devices product market includes SYMPLICITY, EnligHTN, ONESHOT, V 2 and others. Geographically, the market is segmented into North America, Europe, Asia-Pacific and LAMEA. Medtronic, Boston Scientific and Covidien are the major players in the renal denervation device market. As the market is in its nascent stage, key players are engaged in research and development to introduce highly differentiated and innovative products in the market.

Key Benefits

This report provides an in-depth analysis of the renal denervation device market with current trends and estimations through 2013-2020.
Geographic analysis of the market would help companies to plan their strategies accordingly and take region specific decisions
Analysis of key strategies adopted by market players would provide market intelligence and help stakeholders understand the competitive structure of the market